"Testicular Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
| Descriptor ID |
D013736
|
| MeSH Number(s) |
C04.588.322.762 C04.588.945.440.915 C12.294.260.937 C12.758.409.937 C19.344.762 C19.391.829.782
|
| Concept/Terms |
Testicular Neoplasms- Testicular Neoplasms
- Neoplasm, Testicular
- Testicular Neoplasm
- Testicular Tumors
- Testis Neoplasms
- Neoplasms, Testicular
- Neoplasms, Testis
- Neoplasm, Testis
- Testis Neoplasm
Tumor of Rete Testis- Tumor of Rete Testis
- Rete Testis Tumor
- Rete Testis Tumors
- Testis Tumor, Rete
- Testis Tumors, Rete
Cancer of Testis- Cancer of Testis
- Testis Cancers
- Testis Cancer
- Cancer, Testis
- Cancers, Testis
- Cancer of the Testes
- Cancer of the Testis
- Testicular Cancer
- Cancer, Testicular
- Cancers, Testicular
- Testicular Cancers
|
Below are MeSH descriptors whose meaning is more general than "Testicular Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Testicular Neoplasms".
This graph shows the total number of publications written about "Testicular Neoplasms" by people in this website by year, and whether "Testicular Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 0 | 7 |
| 1996 | 2 | 2 | 4 |
| 1997 | 6 | 1 | 7 |
| 1998 | 9 | 0 | 9 |
| 1999 | 6 | 4 | 10 |
| 2000 | 6 | 1 | 7 |
| 2001 | 8 | 0 | 8 |
| 2002 | 8 | 2 | 10 |
| 2003 | 10 | 0 | 10 |
| 2004 | 11 | 1 | 12 |
| 2005 | 8 | 2 | 10 |
| 2006 | 10 | 1 | 11 |
| 2007 | 14 | 2 | 16 |
| 2008 | 13 | 0 | 13 |
| 2009 | 8 | 1 | 9 |
| 2010 | 12 | 0 | 12 |
| 2011 | 5 | 2 | 7 |
| 2012 | 10 | 1 | 11 |
| 2013 | 12 | 0 | 12 |
| 2014 | 10 | 0 | 10 |
| 2015 | 8 | 1 | 9 |
| 2016 | 7 | 0 | 7 |
| 2017 | 10 | 0 | 10 |
| 2018 | 5 | 1 | 6 |
| 2019 | 13 | 2 | 15 |
| 2020 | 3 | 0 | 3 |
| 2021 | 7 | 0 | 7 |
| 2022 | 6 | 1 | 7 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Testicular Neoplasms" by people in Profiles.
-
Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases. Hum Pathol. 2024 Nov; 153:105673.
-
Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors. Clin Genitourin Cancer. 2024 Dec; 22(6):102242.
-
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial. J Clin Oncol. 2024 Oct; 42(28):3270-3276.
-
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. Gynecol Oncol. 2024 07; 186:117-125.
-
Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. Cancer. 2023 10 15; 129(20):3300-3308.
-
Reprint of: somatic-type malignancies in testicular germ cell tumors. Hum Pathol. 2023 03; 133:102-114.
-
How Do Cancer-Specific Computed Tomography Protocols Compare With the American College of Radiology Dose Index Registry? An Analysis of Computed Tomography Dose at 2 Cancer Centers. J Comput Assist Tomogr. 2023 May-Jun 01; 47(3):429-436.
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial. Lancet Oncol. 2022 11; 23(11):1378-1388.
-
Imaging of pediatric testicular tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer. 2023 06; 70 Suppl 4:e29988.
-
Germ cell tumors: Similar histology, ubiquitous distribution. Semin Diagn Pathol. 2023 01; 40(1):1.